Department of Gastroenterology, The Shanghai Tenth People's Hospital, Department of Bioinformatics, School of Life Sciences and Technology, Tongji University, Shanghai, People's Republic of China.
Guangdong Institute of Gastroenterology, Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, Department of Colorectal Surgery, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, People's Republic of China.
Nat Commun. 2021 May 24;12(1):3063. doi: 10.1038/s41467-021-23265-y.
Associations between gut microbiota and colorectal cancer (CRC) have been widely investigated. However, the replicable markers for early-stage adenoma diagnosis across multiple populations remain elusive. Here, we perform an integrated analysis on 1056 public fecal samples, to identify adenoma-associated microbial markers for early detection of CRC. After adjusting for potential confounders, Random Forest classifiers are constructed with 11 markers to discriminate adenoma from control (area under the ROC curve (AUC) = 0.80), and 26 markers to discriminate adenoma from CRC (AUC = 0.89), respectively. Moreover, we validate the classifiers in two independent cohorts achieving AUCs of 0.78 and 0.84, respectively. Functional analysis reveals that the altered microbiome is characterized with increased ADP-L-glycero-beta-D-manno-heptose biosynthesis in adenoma and elevated menaquinone-10 biosynthesis in CRC. These findings are validated in a newly-collected cohort of 43 samples using quantitative real-time PCR. This work proves the validity of adenoma-specific markers across multi-populations, which would contribute to the early diagnosis and treatment of CRC.
肠道微生物群与结直肠癌(CRC)之间的关联已被广泛研究。然而,在多个人群中,用于早期腺瘤诊断的可重复标志物仍然难以捉摸。在这里,我们对 1056 个公共粪便样本进行了综合分析,以确定用于 CRC 早期检测的腺瘤相关微生物标志物。在调整了潜在的混杂因素后,使用 11 个标志物构建随机森林分类器来区分腺瘤与对照(ROC 曲线下面积(AUC)= 0.80),使用 26 个标志物区分腺瘤与 CRC(AUC = 0.89)。此外,我们在两个独立的队列中验证了分类器,分别达到了 0.78 和 0.84 的 AUC。功能分析表明,改变的微生物组的特征是腺瘤中 ADP-L-甘油-D-甘露庚糖的生物合成增加,CRC 中menaquinone-10 的生物合成增加。使用定量实时 PCR 在一个新收集的 43 个样本的队列中验证了这些发现。这项工作证明了多人群中腺瘤特异性标志物的有效性,这将有助于 CRC 的早期诊断和治疗。